Advances in neutropenia research could pave the way for better treatments

Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood.

Sarepta’s Elevidys secures US label expansion for DMD – Pharmaceutical Technology

Elevidys uses a recombinant adeno-associated virus vector serotype 74 (AAV74) to deliver a dystrophin encoding microdystrophin transgene. Credits: T. Schneider/Shutterstock.com Just a week after Pfizer

June 21, 2024

HHS Finalizes Rule for AI Transparency and Data Interoperability

What You Should Know: – The U.S. Department of Health and Human Services (HHS) took a major step forward in healthcare data sharing and artificial

December 13, 2023

Pager Health Unveils 3 New GenAI Apps to Personalize Member Experiences

What You Should Know: – Pager Health, a virtual-care platform, announces the development of three new generative AI (GenAI) applications designed to streamline care navigation

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.